Add Yahoo as a preferred source to see more of our stories on Google. A simple blood test may reveal your 10-year risk of liver disease. (CREDIT: Shutterstock) Cirrhosis and liver cancer are two of ...
By Dennis Thompson HealthDay ReporterMONDAY, March 2, 2026 (HealthDay News) — A new, easy-to-use blood test can identify when a person’s liver disease is being driven by too much drinking, researchers ...
Researchers have recently created a blood test that can detect liver disease years before symptoms ever develop, helping pave the way for the diagnosis of diseases such as cirrhosis and liver cancer ...
Cancer diagnostics firm Helio Genomics says its five-year clinical trial shows its AI-based diagnostic test is two to four times more effective than typical ultrasounds. Helio’s pivotal trial, which ...
An intelligent liver function test platform (iLFT) successfully integrated into one Scottish primary care system reduced unnecessary specialist referrals over a 5-year period, and improved triage for ...
An increasing number of people are discovering fatty liver during routine ultrasound tests, often without any obvious symptoms. Doctors explain what this finding really means, why it is becoming more ...
A novel artificial intelligence blood testing technology developed and used by Johns Hopkins Kimmel Cancer Center to successfully detect lung cancer in a 2021 study has now detected more than 80% of ...
Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go ...
Hosted on MSN
Elevated Liver Enzymes and What They Might Mean
Elevated liver enzymes can occur for many reasons. Most often, elevated liver enzymes are temporary and resolve on their own without treatment. Occasionally, elevated liver enzymes require additional ...
In a cohort study of nearly 16,000 US patients with breast cancer who were prescribed a cyclin-dependent kinase (CDK) 4/6 inhibitor, only 46% underwent liver function testing in the 2 weeks before ...
Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safety communication on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results